Regulatory updateRetina
Faricimab: start with the current EU product information
The EMA Vabysmo record is the authoritative entry point for EU product information, assessment documents and authorised indications.
European Medicines Agency ↗Evidence, trials and EU product information for faricimab.
Current product information · EMA ↗ · 20 Sept 2026
The EMA Vabysmo record is the authoritative entry point for EU product information, assessment documents and authorised indications.
European Medicines Agency ↗